For example, circRAPGEF5 medicated ferroptosis by modulating alternative splicing of TFRC in endometrial cancer, and circRAPGEF5/RBFOX2 axis might be a cancer therapy target (Zhang et al., 2022). This evidence concerns the gene TFRC and endometrial cancer.